This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Peptides & Oligonucleotides

Drug Delivery of Oligonucleotides, Peptides, RNA, mRNA and CRISPR - WHITEPAPER


Download the exclusive whitepaper

Research and innovation in drug delivery systems is a rapidly evolving field, especially as the scope of drugs now encompasses not only small molecule drugs but also biological macromolecules including DNA, RNA, proteins and peptides. As a field that has seen fast paced expansion as far as research and development is concerned, it encounters many challenges in terms of development of delivery systems catering to these novel drug entities.

This whitepaper explores the latest innovations, strategies and challenges of drug delivery of oligonucleotides, peptides, RNA, mRNA and CRISPR, including:

  • Novel Technologies for the Delivery of Macromolecular Therapeutics

  • Novel Polymeric Delivery Vehicles

  • mRNA Lipid Nanoparticles

  • Antibody Drug Conjugates (ADCs)

  • Extra-Hepatic Delivery of Oligonucleotides (siRNA and ASOs)

  • RNAi Delivery to Hepatic System

  • RNAi Delivery to Non-hepatic Systems

  • Antibody-Oligonucleotide Conjugates (AOCs)

  • Delivery of siRNA Conjugates

  • Innovations in Peptide Delivery

  • Adhesive Dermally Applied Microarray (ADAM)

  • Peptides as a Delivery Vehicle

  • Delivery of Peptide Therapeutics Inside Cells

  • Strategies for delivery of CRISPR and mRNA

To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content. 


This piece represents the views of the author and not necessarily the views of Informa Connect Life Sciences or the Antibody Therapeutics and Engineering conference series.

ABOUT THE AUTHOR: Poonam Balani, PhD, is a medical writer covering pharmaceutical and biomedical niche. She has authored whitepapers in regulatory sciences, cell and gene therapies and contributed to medical encyclopedias and editorial summaries.

Have any questions about the report or interested in sponsoring a future whitepaper? Email

Log in or Create an Informa Connect Account to Access this content

Creating an account also means you'll get special access to article updates and exclusive industry content.